Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2023.1195142 Immunology Correction Corrigendum: Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: impact of CMV infection and leukemia relapse Luo Xiao-Hua 1 2 * † Poiret Thomas 2 Liu Zhenjiang 2 Meng Qingda 2 Nagchowdhury Anurupa 2 Ljungman Per 3 4 1 Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China 2 Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden 3 Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital and Division of Hematology, Stockholm, Sweden 4 Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden

Edited and Reviewed by: Hermann Einsele, Julius Maximilian University of Würzburg, Germany

*Correspondence: Xiao-Hua Luo, xiaohua.luo@gmail.com

†ORCID: Xiao-Hua Luo, orcid.org/0000-0002-0657-7738

03 05 2023 2023 14 1195142 28 03 2023 21 04 2023 Copyright © 2023 Luo, Poiret, Liu, Meng, Nagchowdhury and Ljungman 2023 Luo, Poiret, Liu, Meng, Nagchowdhury and Ljungman

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A corrigendum on Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: impact of CMV infection and leukemia relapse by Luo X-H, Poiret T, Liu Z, Meng Q, Nagchowdhury A and Ljungman P (2023) Front. Immunol. 13:1027593. doi: 10.3389/fimmu.2022.1027593 cytomegalovirus WT1 = Wilms tumor 1 immune reconstitution stem cell transplantation acute myeloid leukemia (AML) section-in-acceptance Alloimmunity and Transplantation

In the published article, there was an error. The original version of this article inadvertently contained a typographical error.

A correction has been made to Materials and Methods, Determination and characterization of CMV-specific and WT1-specific CD8+ T cells by MHC-Dextramer analyses, Paragraph 1. This sentence previously stated:

“CMV-specific T cells (CMV-CTL) and WT1-specific T cells (WT1-CTL) frequencies were quantified and phenotyped in patients by staining with PE-A*0201 CMVNLVPMVATV Dextramer, PE-A*0201 WT1SLLFLLFSL Dextramer and APC-A*0201 WT1VLPLTVAEV Dextramer (Immunex, Copenhagen, Denmark) (Supplementary Figure 1).”

The corrected sentence appears below:

“CMV-specific T cells (CMV-CTL) and WT1-specific T cells (WT1-CTL) frequencies were quantified and phenotyped in patients by staining with PE-A*0201 CMVNLVPMVATV Dextramer, PE-A*0201 WT1RMFPNAPYL Dextramer and APC-A*0201 WT1SLGEQQYSV Dextramer (Immudex, Copenhagen, Denmark) (Supplementary Figure 1).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.